Motif Bio Share Discussion Threads

[timbo003] 21/4/2016 20:42

Thanks tromso

There's also another new interview with the Motif CEO over on ProactiveInvestor:


It sounds like a Nasdaq listing could happen this year and if the clinical program proceeds as planned the shares may be in for a very significant re-rating.

Links to all three of today's interviews now listed in the header.

[tromso1] 21/4/2016 15:43

And then from 16:15...

"Within 15 to 18 months, there's no reason why Motif shouldn't be somewhere in the $800-$900 million market cap range if we do everything as we've demonstrated we can do."

"There's a tremendous opportunity for growth in a relatively short period of time."

[tromso1] 21/4/2016 15:32

An interview with the CEO on the latest Sharepickers podcast just out (462).



He reckons that the benchmark they are aiming for in the next 15 to 18 months is that of Cempra with a $900m market cap.

A $900m market cap vs the current of £44m is a pretty huge uplift.


From 10:30 -

"The best comparable for us right now is a company called Cempra...they are basically where Motif expects to be in the second half of 2017...the market capitalisation of Cempra today...$900m. If we do everything right, that would be a benchmark for us within the next 15 to 18 months"

[timbo003] 21/4/2016 14:04

There's a new audio interview with the Zeus capital analyst on Directors talk, who's risk adjusted valuation for Motif is currently 174p/share




Dr Gary Waanders at Healthcare Director at Zeus Capital chats with DirectorsTalk about Motif Bio Plc (LON:MTFB) it’s lead product iclaprim, why it’s special, the trials, what it might achieve at peak sales, fair value estimate for the company and how Motif’s current market cap compares to other antibiotic developers with late stage assets.

[thomasthetank1] 20/4/2016 13:10

Read Northland Capital Partners's note on MOTIF BIO, out this morning, by visiting hxxps://www.research-tree.com/company/GB00BVVT4H71
"Motif has met a very aggressive timetable since listing on AIM last year. The company continues to rapidly progress iclaprim towards marketing approval. The drug is set to fill a major market void in the wake of a major global public health crisis driven by rampant antibiotic resistance. Having already been tested on over a thousand patients, the drug’s safety and efficacy is well supported. If approved, the drug could achieve over $1bn/year in sales. We continue to expect the treatment to be approved and launched in 2018..."

[thomasthetank1] 14/4/2016 10:57

Read Northland's note on Motif Bio (MTFB), out this morning, by visiting hxxps://www.research-tree.com/companies/uk/biotechnology/motif_bio_plc …
“Motif continues to strengthen its management team. Pete Meyers has strong experience in capital markets, M&A, and financial operations—which will be instrumental to the financial management of the group as it expands. Rajesh Shukla’s deep clinical operations experience will ensure the proper execution of Motif’s pivotal trials…”

[pjj71] 14/4/2016 08:03

Surely the appointments are good news.. lining the business up for its NASDAQ listing...

[godolphin] 23/3/2016 11:15

It's non regulatory. You can add that in if you edit columns add non regulatory.

[regandharry5] 23/3/2016 07:30

Another positive RNS. Wonder why it's not flagged up on the monitor page by advfn.

[regandharry5] 14/3/2016 07:47

Another positive RNS.. I suppose that's where the real money is for this. the USA.

[regandharry5] 09/3/2016 12:39

Current share price showing 45p...Offer price 44.5p. ???????

[timbo003] 02/3/2016 23:03

>>Thanks godolphin, link now in the header

[timbo003] 22/2/2016 07:22

A date for the diaries

March 9th 16.00 GMT

[cheshire man] 21/2/2016 16:47

Investors Chronicle
Which companies are stepping up to the challenge of antibiotic-resistant superbugs? @AlexNewman_IC reports

[regandharry5] 19/2/2016 17:37

Yes, not sure about the time line regarding the listing on the Nasdaq.

But when it comes that will be the trigger for the real movement here.

[victor2] 19/2/2016 14:23

looks like the seller has been taken out onwards and upwards.

[godolphin] 05/2/2016 13:27

More garbage! Why 3D? You appear to be the troll here!